Role of vascular endothelial growth factor-C and -D mRNA in breast cancer

Hiroshima Journal of Medical Sciences

Volumn 57, Issue 2, 2008, Pages 73-78

  Teramoto, Seiichi ^a,b,d   Arihiro, Koji ^c   Koseki, Masato ^b   Kataoka, Tsuyoshi ^a   Asahara, Toshimasa ^a   Ohdan, Hideki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

^c HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^d KYUSHU CENTRAL HOSPITAL   (Japan)

Author keywords

Breast cancer; VEGF C; VEGF D

Indexed keywords

MESSENGER RNA; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, STATISTICAL; RNA, MESSENGER; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 51749109768     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Achen, M.G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A.F., Alitalo, K and Stacker, SA. 1998. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl.Acad.Sci. U S A. 95: 548-553.
2. Achen, M.G., Williams, R.A., Minekus, M.P., Thornton, G.E., Stenvers, K., Rogers, P.A., Lederman, F., Roufail, S. and Stacker, S.A. 2001. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogensis. J. Pathol. 193: 147-154.
3. Amioka, T., Kitadai, Y., Tanaka, S., Haruma, K., Yoshihara, M., Yasui, W. and Chayama, K. 2002. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinoma invading the submucosa. Eur. J. Cancer 38: 1413-1419.
4. Beck, L.J. and D'Amore, P. 1997. Vascular Development: cellular and molecular regulation. FAFEB J. 11: 365-373.
5. Bunone, G., Vigneri, P., Mariani L., Buto, S., Collini, P., Pilotti, S., Pierotti M.A. and Bongarzone, I. 1999. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am. J.Pathol. 155: 1967-1976.
6. Ellis, L. and Fidler, I. 1996. Angiogenesis and metastasis. Eur. J. Cancer 32A: 2451-2460.
7. Furudoi, A., Tanaka, S., Haruma, K., Kitadai, Y., Yoshihara, M., Chayama, K. and Shimamoto, F. 2002. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectalcarcinoma. Oncology 62: 157-166.
8. George, M.L., Tutton, M.G., Janssen, F., Arnaout, A., Abulafi, A.M., Eccles, S.A. and Swift, R.I. 2001. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3: 420-427.
9. Gusterson, B.A., Gelber, R.D., Goldhirsch, A., Price, K.N., Säve-Söderborgh, J., Anbazhagan, R., Styles, J., Rudenstam, C.M., Golouh, R. and Reed, R. 1992. Prognostic significance of c-erbB-2 expression in breast cancer. J. Clin. Oncol. 10: 1049-1056.
10. Ishikawa, M., Kitayama, J., Kazama, S. and Nagawa, H. 2004. The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia. Hepatogastroenterology 51: 1319-1322.
11. Jüttner, S., Wissmann, C., Jöns, T., Vieth, M., Hertel, J., Gretschel, S., Schlag, P.M., Kemmner, W. and Höcker, M. 2006. Vascular endothelial growth factor-D and Its Receptor VEGFR-3: Two Novel Independent Prognostic Markers in Gastric Adenocarcinoma. J. Clin.Oncol. 24: 228-240.
12. Kaipainen, A., Korhonen, J., Mustonen,T., van Hinsbergh, V., Fang, G., Dumont, D., Breitman, M. and Alitalo, K. 1995. Expression of the fms-liketyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. 92: 3566-3570.
13. Kawakami, M., Furuhata, T. and Kimura, Y. 2003. Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer. J. Exp. Clin. Cancer Res. 22: 229-237.
14. Kinoshita, J., Kitamura, K., Kabashima, A., Saeki, H., Tanaka, S. and Sugimachi, K. 2001. Clinical significance of vascular endothelial growth factor -C(VEGF-C) in breast cancer. Breast Cancer Res. Treat. 66: 159-164.
15. Koyama, Y., Kaneko, K., Akazawa, K., Kanbayashi, C., Kanda, T. and Hatakeyama, K. 2003. Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. Clin. Breast Cancer 4: 354-360.
16. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V, and Alitalo, K. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development. (Camb.) 122: 3829-3837.
17. Kurebayashi, J., Otsuki, T., Kunisue, H., Mikami, Y., Tanaka, K., Yamamoto, S. and Sonoo, H. 1999. Expression of vascular endothelial growth factor(VEGF) family members in breast cancer. Jpn. J. Cancer Res. 90: 977-981.
18. Loureiro, R.M., Maharaj, A.S., Dankort, D., Muller, W.J. and D'Amore, P.A. 2005. ErbB2 over-expression in mammary cells upregulates VEGF through the core promoter. Biochem. Biophys. Res. Commun. 326: 455-465.
19. Mihaela, S., Thomas, H., David, D.J., Remko, P., Lauren, J., Paula, V., Lucia, R., Kari, A., Kevin, C. and Michael, D. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7: 192-199.
20. Nakamura, Y., Yasuoka, H., Tsujimoto, M., Yang, Q., Imabun, S., Nakahara, M., Nakao, K., Nakamura, M., Mori, I. and Kakudo, K. 2003. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin. Cancer Res. 9: 716-721.
21. Niki, T., Iba, S., Tokunou, M., Yamada, T., Matsuno, Y. and Hirohashi, S. 2000. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin. Cancer Res. 6: 2431-2439.
22. O-charoenrat, P., Rhys-Evans, P. and Eccles, S.A. 2001. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92: 556-568.
23. Oh, S.J., Jeltsch, M.M., Birkenhager, R., McCarthy, J.E., Weich, H.A., Christ, B., Alitalo, K. and Wilting, J. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188: 96-109.
24. Onogawa, S., Kitadai, Y., Tanaka, S., Kuwai, T., Kimura, S. and Chayama, K. 2004. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci. 95: 32-39.
25. Salven, P., Lymboussaki, A., Heikkila, P., Jaaskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K. and Joensuu, H. 1998. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am. J. Pathol. 153: 103-108.
26. Singleton, T.P. and Strickler, J.G. 1992. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene. Pathol. Annu. 27: 165-190.
27. Stacker, S.A., Caesar, C., Baldwin, M.E., Thornton, G.E., Williams, R.A., Prevo, R., Jackson, D.G., Nishikawa, S., Kubo, H. and Achen, M.G. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7: 186-191.
28. Tsurusaki, T., Kanda, S., Sakai, H., Kanetake, H., Saito, Y., Alitalo, K. and Koji, T. 1999. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br. J. Cancer 80: 309-313.
29. Yamada, Y., Nezu, J., Shimane, M. and Hirata, Y. 1997. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42: 483-488.
30. Wentao, Y., Kristine, K., Ying, Y., Terry, L.S., Daren, S. and Dihua, Y. 2002. ErbB2 Overexpression Correlates with Increased Expression of Vascular Endothelial Growth Factor A, C, D in Human Breast Carcinoma. Cancer 94: 2855-2861.
31. Yokoyama, Y., Charnock-Jones, D.S., Licence, D., Yanaihara, A., Hastings, J.M., Holland, C.M., Emoto, M., Umemoto, M., Sakamoto, T., Sato, S., Mizunuma, H. and Smith, S.K. 2003. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br. J. Cancer 88: 237-244.
32. Yonemura, Y., Endo, Y., Fujita, H., Fushida, S., Ninomiya, I., Bandou, E., Taniguchi, K., Miwa, K., Ohoyama, S., Sugiyama, K. and Sasaki, T. 1995. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res. 5: 1823-1829.
33. Yu, D., Liu, B., Tan, M., Li, J.Z., Wang, S.S. and Hung, M.C. 1996. Overexpression c-erbB-2/neu in breast cancer cells confers increased resistance to taxol via mdr-1 independent mechanisms. Oncogene 13: 1359-1365.
34. Yu, D., Liu, B., Jing, T., Sun, D., Price, J.E., Singletary, S.E., Ibrahim, N., Hortobagyi, G.N. and Hung, M.C. 1998. Overexpression of both p185c-erbB-2 and p170mdr-1 renders breast cancer cells superresistant to Taxol. Oncogene 16: 2087-2094.
35. Cdc2 kinase. Mol. Cell 2: 581-591.